SELL and osteonecrosis: After FDR adjustment, supporting evidence was found for the correlation between elevated immunologic feature CD62L − monocyte %monocyte and an increased osteonecrosis risk (OR:1.154, q = 0.159), while the immunologic feature Myeloid DC %DC was negatively associated with the risk of drug-induced osteonecrosis (OR:0.753, q = 0.148).